MeVis Medical Solutions AG (ETR:M3V)
Germany · Delayed Price · Currency is EUR 23.60
0.00 (0.00%)
Aug 5, 2026, 5:35 PM CET
ETR:M3V Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 43 | 45 | 42 | 52 | 62 | 59 | |
Market Cap Growth | -4.84% | 7.83% | -19.01% | -16.96% | 4.91% | 2.52% |
Enterprise Value | 39.3 | 38.61 | 35.33 | 43.94 | 52.92 | 51.71 |
Last Close Price | 23.60 | 24.80 | 23.00 | 28.40 | 34.20 | 32.60 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Forward PE | - | 16.98 | 16.98 | 16.98 | 16.98 | 16.98 |
PEG Ratio | - | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
PS Ratio | 2.77 | 2.81 | 2.47 | 2.98 | 3.32 | 3.66 |
PB Ratio | 2.41 | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 |
P/TBV Ratio | 2.41 | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 |
P/FCF Ratio | - | 12.07 | 14.72 | 8.95 | 13.18 | 6.53 |
P/OCF Ratio | - | 11.64 | 13.30 | 8.83 | 12.81 | 6.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 2.54 | 2.40 | 2.08 | 2.53 | 2.82 | 3.19 |
EV/EBITDA Ratio | 6.75 | 4.97 | 3.72 | 4.31 | 5.53 | 5.45 |
EV/EBIT Ratio | 6.75 | 5.07 | 3.77 | 4.35 | 5.58 | 5.52 |
EV/FCF Ratio | - | 10.33 | 12.42 | 7.61 | 11.20 | 5.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Debt / Equity Ratio | -0.20 | -0.37 | -0.37 | -0.43 | -0.52 | -0.43 |
Net Debt / EBITDA Ratio | -0.63 | -0.84 | -0.69 | -0.76 | -0.97 | -0.80 |
Net Debt / FCF Ratio | - | -1.74 | -2.29 | -1.34 | -1.97 | -0.84 |
Asset Turnover | 0.67 | 0.61 | 0.62 | 0.59 | 0.64 | 0.59 |
Quick Ratio | 1.79 | 1.38 | 1.35 | 1.32 | 1.24 | 1.39 |
Current Ratio | 1.87 | 1.42 | 1.39 | 1.36 | 1.27 | 1.44 |
Return on Assets (ROA) | 24.80% | 28.73% | 33.94% | 33.78% | 32.00% | 33.56% |
Return on Invested Capital (ROIC) | 40.52% | 66.57% | 86.57% | 107.68% | 100.47% | 77.11% |
Return on Capital Employed (ROCE) | 29.51% | 38.89% | 47.62% | 51.07% | 47.54% | 47.09% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
FCF Yield | - | 8.28% | 6.80% | 11.17% | 7.59% | 15.30% |
Dividend Yield | 4.79% | 10.10% | 11.75% | 15.07% | 7.30% | 9.61% |
Payout Ratio | - | -144.06% | -107.87% | -158.33% | -58.36% | -125.48% |
Total Shareholder Return | 4.79% | 10.10% | 11.75% | 15.07% | 7.30% | 9.61% |